SARS-CoV-2 (COVID19) iri kutekeshera pasirese, uye jekiseni rinozivikanwa senzira ine hupfumi uye inoshanda yekudzora denda rehutachiona.Kuongororwa kwejekiseni rechinyakare kunowanzo shandisa nzira dzekuona kuti masoja ekudzivirira chirwere ari kushomeka kuti aongorore kushanda kwejekiseni kuburikidza nemiedzo yekusagadzikana;
Nzira dzechinyakare dzinotora nguva uye dzakadzikira mukubudirira, kazhinji kutora mazuva maviri kusvika mana kuti apedze kuongorora, uye nekuti mazhinji acho anoshandisa hutachiona mhenyu, Inoda kuitwa mubiosafety level 3 kana pamusoro murabhoritari, inova nguva- kudya uye kushanda nesimba, uye kunounza kukanganisa kukuru pakuongororwa kwekuwedzera nekuunganidza.Nokudaro, pane chido chekukurumidzira cheimwe nzira iri nyore uye yakakurumidza iyo inokodzera kuongororwa kwezvidziviriro zvekudzivirira muhuwandu hwevanhu.
Aehealth COVID19 Neutralization Antibody Quantitative Test Kit inoshandiswa pakuonekwa kwehuwandu hweCOVID19 inoderedza masoja ekudzivirira chirwere muserum yevanhu, plasma kana ropa rose.Inogona kushandiswa kukurumidza, kuwanda uye yakanyanya kutaridzika kuona mu vitro.kiriniki inoshandiswa mukuwedzera kuongororwa kwemhedzisiro yeiyo nyowani yekudzivirira yekoronavirus uye ongororo yekudzivirira kurwisa masoja ekudzivirira chirwere muvarwere vakapora mushure mekutapukirwa.
Neutralizing masoja ekudzivirira chirwere anomisa hutachiona nekuvharisa kusangana pakati pehutachiona hweCOVID19 nemaseru anotambira.Mazhinji masoja ekudzivirira chirwere anopindura kune receptor binding domain (RBD) yespike protein, inosunga yakananga kune cell surface receptor ACE2.masoja ekudzivirira chirwere-pamhepo parizvino anopa masoja ekudzivirira chirwere maviri anoenderana necone CR3022.Nepo akawanda S-protein RBD anosunga masoja ekudzivirira chirwere achikwikwidza antigen kusunga neACE2, iyo CR3022 epitope haipindire neACE2-inosunga saiti.
Saka hazvitadzise kusungirirwa kwekudzivirira ma antibodies.Nepo CR3022 payo pachayo ichiratidzira chete isina kusimba mhedzisiro, yakaratidza kuwirirana nemamwe maS-protein RBD anosunga masoja ekudzivirira chirwere kuti asaite COVID19.
Easy operation
- Hapana vanoda nyanzvi kudzidziswa;
- Yakaderera sampuli kudiwa, inongoda 50 μL;
- Inopindirana nemhando dzakawanda dzemuenzaniso: Serum/Plasma/Ropa rose.
Kunzwa kwakanyanya
- Sensitivity: 98.95%;
- Kunyatsojeka: 100%.
Effificient
- Nguva yekuita: 15 mins, Nguva yekuedza: 10s;
- Protable, Wide kushandiswa mamiriro;
- Yakavakwa-mukati bhatiri, anopfuura mazana maviri bvunzo pasina simba rekuisa.
Kuvimbika
- Yakasimbiswa ne3600 bvunzo dzekiriniki, 1500 bvunzo nemuenzaniso wemunhu ane hutachiona, 900 bvunzo dzevajekiseni, 1200 bvunzo nevanhuwo zvavo.;
- Data yekiriniki inotorwa kubva kune vajekiseni ne inactivated vaccine, nucleic acid vaccine, protein vaccine, uye vanhu vane hutachiona, vanhuwo zvavo.
- Cheka kukosha inhibition rate ye30%.
Nheyo yakakosha inoshandiswa mukiti iyi ndeye immunochromatographic competition.Mutsetse wekuona (T-line) patest strip wakaputirwa neangiotensin inoshandura enzyme 2 uye mutsara wekutonga (C-line) wakaputirwa nembudzi inorwisa tsuro IgG antibody. conjugate pad yakavharwa nefluorescently yakanyorwa kuti COVID19 RBD protein uye fluorescently yakanyorwa rabbit IgG antibody.Panguva yekuonekwa, kana sampu ine antibody inofanirwa kuongororwa, conjugate yechinhu chekuyedza mumuenzaniso uye iyo fluorescent antigen inoumba immune complex uye immune complex haichakwanisa kusunga kune angiotensin-inoshandura enzyme 2 isingafambiswe pane nitrocellulose membrane. .Iyo fluorescent antigen conjugate isina kusungwa kune masoja ekudzivirira chirwere anoongororwa anosunga kune angiotensin inoshandura enzyme 2 isingafambire panitrocellulose membrane kugadzira mutsara wekuona (T).
- Kuongororwa bvunzo pamberi pekudzivirira;
- Kuongorora mhedzisiro mushure mekudzivirira;
- Kuongororwa kwengozi yechirwere chechipiri chevanhu vane utachiona;
- Kuongororwa kwenjodzi kune vanhuwo zvavo (kusanganisira asymptomatic infection) mukana wekutapukirwa;
- Virus resistance kugona kuyedzwa.